Gi-Biome is a company that leads the future of disease treatment through innovative microbiome combo therapy.
Industry
Sector :
Subsector :
Keywords :
IPO status
Private
Description
Gi-Biome specializes in research and development for the intestinal immune system and the microbiome. They are at the forefront of using a groundbreaking microbiome combo therapy to treat diseases. This therapy has the potential to revolutionize disease treatment by targeting the microbiome, which plays a crucial role in maintaining a healthy immune system. Gi-Biome's innovative approach has the potential to provide more effective and personalized treatments for a wide range of diseases.